Longitudinal analysis of neutralization in sera from HCWs receiving 2 doses of Omicron BA.4/5-adapted bivalent vaccine - 13/10/23
Doi : 10.1016/j.jinf.2023.08.012
Masayuki Amano ⁎ 
Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan
⁎Correspondence to: Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Cyuo-ku, Kumamoto 860-0811, Japan.Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University2-2-1 Honjo, Cyuo-kuKumamoto860-0811Japan
Yasuko Ichikawa, Shota Matsumoto
Kumamoto General Hospital, Japan Community Healthcare Organization, Kumamoto, Japan
Shuzo Matsushita
Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan
Hiroaki Mitsuya
Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 5
P. e79-e82 - novembre 2023 Retour au numéro
Article précédent
- Identifying opportunities to improve the microbiological diagnosis of tuberculosis in a low endemic urban setting
- Jenny Clarke, Matthew P. Moore, Matthew K. O’Shea, Martin Dedicoat
- Post-Covid-19 condition: A comprehensive analysis of the World Health Organisation definition
- Laure Carcaillon-Bentata, Tatjana T. Makovski, Caroline Alleaume, Valentina Decio, Nathalie Beltzer, Anne Gallay, Sarah Tebeka, Olivier Robineau, Joël Coste
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?